Introduction
Most, if not all, organisms possess mechanisms to repair DNA strand breaks generated by DNA damaging agents. A number of mutant ®broblast or lymphocyte cell lines have been isolated that are defective in DNA strand-break repair or the V(D)J recombination in the immunoglobulin and T-cell receptor loci. These mutants include severe combined immuno-de®ciency (scid, XRCC7) and Ku80-de®ciency (XRCC5) and comprise several complementation groups. SCID mice are sensitive to ionizing radiation because of their reduced ability to perform DNA strand-break repair. They also lack B-and T-cell immunity as a result of the de®ciency in performing V(D)J recombination. The catalytic subunit of DNA-dependent protein kinase (DNA-PK) was identi®ed as the SCID gene by genetic complementation (Blunt et al., 1995; Kirchgessner et al., 1995) . The kinase activity in vitro is absent in cell extracts prepared from SCID cells and human malignant glioma cell line, M059J (Lees-Miller et al., 1995) . DNA-PK is a multimeric nuclear serine/ threonine protein kinase, consisting of a 465 kDa catalytic subunit (DNA-PKcs) and a heterodimeric DNA binding component termed Ku70 and Ku80, which is implicated in the regulation of doublestranded DNA (dsDNA) breaks (Gottlieb and Jackson 1993; Mimori et al., 1990; Reeves and Sthoeger, 1989) . When activated by dsDNA, the kinase phosphorylates various DNA binding proteins in vitro, including Sp1 (Jackson et al., 1990) , p53, the SV40 large T antigen (Carter et al., 1990; Lees-Miller et al., 1990) , and c-Abl . DNA-PK is also known to be inactivated by autophosphorylation (Chan and Lees-Miller, 1996) . Although DNA-PK has been speculated to act by regulating DNA repair, recombination, or transcription machinery, the precise mechanism of its action remains obscure.
Poly(ADP-ribose) polymerase (PARP) (EC 2.4.2.30) (de Murcia and MeÂ nissier de Murcia, 1994; Lindahl et al., 1995; Ueda and Hayaishi, 1985) also binds to and is activated by DNA strand breaks. PARP catalyzes the transfer of ADP-ribosyl moiety from its substrate NAD + to various nuclear proteins including PARP itself, histone H1 (Ferro and Olivera, 1982; Ueda et al., 1975) , and DNA topoisomerase type II (Darby et al., 1985) . PARP contains three functional domains: (1) the amino-terminal DNA-binding domain that contains two zinc ®nger motifs; (2) the central domain which serves as a target for automodi®cation by poly(ADPribosyl)ation; and (3) the carboxy-terminal catalytic domain. PARP is highly conserved among higher eukaryotes but is absent in yeasts. PARP has also been suggested to play roles in multiple events such as DNA repair (Durkacz et al., 1980; Molinete et al., 1993; Sato and Lindahl, 1992) , genomic stability (MeÂ nissier de Murcia et al., 1997), gene expression (Ohtsuki et al., 1984) , cell death (Zhang et al., 1994) , cell dierentiation (Taniguchi et al., 1988) and HIV infection (Rice et al., 1993a,b; Yamagoe et al., 1991) . Although the PARP-de®cient mice are viable and fertile (Wang et al., 1995; , the mice or their cells show an increased sensitivity to DNA damage in¯icted by g-radiation or an alkylating agent (MeÂ nissier de Murcia et al., 1997) .
Genetic interaction between PARP and DNA-PK in mice has recently been reported . Little is known, however, about the molecular nature of such interaction. Figure 1 Puri®cation of the HIRE-binding proteins from nuclear extracts of MT-2 cells. (a) SDS ± PAGE analysis of anity puri®ed HIRE-binding proteins. Proteins were visualized by silver staining. MW, protein molecular size markers; NE, crude nuclear extracts; DNA-a, DNA-anity-puri®ed proteins. I ± IV denote four major bands of 4200 kDa, 115 kDa, 85 kDa, and 70 kDa, respectively. (b) UV cross-linking of proteins to DNA. 32 P-end-labeled probe synthesized using bromo-dUTP was incubated with MT2 nuclear extracts for 15 min in the absence or presence of an unlabeled speci®c (HIRE) or control (DHIRE) competitor. The reaction mixture was then UV-irradiated for 20 min with the inverted transilluminator and then treated with DNase I. The reaction mixture was electrophoresed in 7.5% SDS ± polyacrylamide gel. After staining, the gel was autoradiographed. (c) South-western blot analysis of anity puri®ed proteins detected with a HIRE-DNA probe. Only a 115 kDa protein was detected. (d) DNA-binding activity of proteins eluted from SDS ± polyacrylamide gel and renatured. Proteins in the individual bands as shown in a (I ± IV) were eluted from the gel, renatured, and assayed for the DNA-binding activity by EMSA using 32 P-labeled HIRE probe in the presence (+) or absence (7) of 100-fold excess HIRE oligonucleotide as a competitor
We have recently discovered that an internal segment, termed HIRE, of human T-cell leukemia virus type I (HTLV-I) provirus shows a promoter activity to drive the expression of the viral transforming gene, tax (Ariumi et al., 1997; Nosaka et al., 1993) . During an attempt to purify proteins that binds to HIRE using DNA-anity chromatography (Kawaguchi et al., 1989) , we found that DNA-PK and PARP were always co-puri®ed. We therefore examined whether these proteins directly interact with each other and whether they modify each other's function.
Results
Co-puri®cation of DNA-PK and PARP as HIRE-binding proteins
To puri®y HIRE-binding proteins, we performed DNA anity chromatography of crude nuclear extracts from the HTLV-I-infected T-cell line, MT2, using dsDNAcoupled latex particles (Kawaguchi et al., 1989) . SDS ± PAGE analysis of the DNA-bound fraction revealed four major bands I ± IV (approximate sizes: 4200, 115, 85 and 70 kDa, respectively) of roughly equimolar intensities together with a number of minor bands ( Figure 1a) . UV cross-linking experiments with crude MT2 nuclear extracts showed that 70 kDa and 115 kDa proteins, among others, could bind to the HIRE DNA (Figure 1b) . Unexpectedly, however, the binding of all these proteins was inhibited, to some extent, even by the control competitor (DHIRE) (Figure 1b) . A 115 kDa protein was also detected by Southwestern blotting (Figure 1c ). Using the proteins separated by SDS ± PAGE and renatured in vitro, we observed that the 70 kDa (IV) and 115 kDa (II) proteins could bind to a 46 bp HIRE probe in the electrophoretic mobility shift assay (EMSA) ( Figure  1d ). Interestingly, the 115 kDa protein (II) gave a smear pattern in this assay (Figure 1b) . UV crosslinking and EMSA indicated that neither 85 kDa protein (III) nor 4200 kDa protein (I) binds to the DNA directly (Figure 1b and d) .
We determined the partial amino acid sequences of the 70 kDa (IV), 85 kDa (III), and 115 kDa (II) proteins and identi®ed them as Ku70, Ku80, and poly(ADP-ribose) polymerase (PARP), respectively (Table 1) . We could not obtain clear sequencing data with the 4200 kDa (I) protein sample. Since Ku 70 and Ku 80 are subunits of the DNA-PK complex and the catalytic subunit of DNA-PK (DNA-PKcs) has a relatively large molecular weight (465 kDa), we tested the possibility that the HIRE-binding protein I (4200 kDa) was DNA-PKcs. Immunoprecipitation with an anti-DNA-PKcs antibody indicated that this was indeed the case (Figure 2) .
During puri®cation of DNA-binding proteins using a dsDNA corresponding to the U5 region of HTLV-1 LTR (44 bp) which has no obvious sequence similarity with HIRE, we also detected a similar set of major bands with equimolar intensities (data not shown). This result and the above competition data (Figure 1b) suggest that both DNA-PK and PARP can associate with dsDNA fragments with little sequence-speci®city. Although these proteins were of little value for our initial purpose of studying proteins that bind speci®cally to HIRE, the functional relationship between PARP and DNA-PK were not well understood and we therefore decided to study this issue further.
Phosphorylation of PARP by DNA-PK
First, we tested whether DNA-PK directly phosphorylates PARP in vitro (Figure 3a) . Consistent with previous reports (Carter et al., 1990; Lees-Miller et al., 1990; Chan et al., 1996) , puri®ed DNA-PK (Promega) strongly auto-phosphorylated its catalytic subunit (465 kDa DNA-PKcs) in a dsDNA-dependent manner ( Figure 3a , lane 2). Importantly, DNA-PK also phosphorylated puri®ed PARP only when dsDNA was present ( Figure 3a , lane 6). We also observed phosphorylation of puri®ed recombinant human PARP expressed in E. coli by DNA-PK in a dsDNAdependent manner (data not shown). Furthermore, DNA-PK was found to phosphorylate the recombinant Figure 2 Identi®cation of the HIRE-DNA binding protein I (4200 kDa). Puri®ed DNA-PK and DNA-anity-puri®ed proteins of MT-2 were immunoprecipitated with antiserum against DNA-PKcs. Normal rabbit IgG was used as a control. The proteins were resolved by electrophoresis in 7% SDS ± polyacrylamide gel and visualized by silver staining 88 kDa mutant PARP protein (PARPDN), which lacked the N-terminal DNA-binding domain (amino acids 7 ± 232) (Figure 3b ), suggesting that at least a major target site(s) for the phosphorylation resides within the portion remaining in this mutant.
To further con®rm the phosphorylation of PARP by DNA-PK, we performed the DNA-PK assay using a pair of human malignant glioma cell lines, M059K and M059J, since Lees-Miller et al. (1995) have previously reported that the DNA-PK activity was absent in the cell extract from radiosensitive M059J cells. Consistent with the previous report, DNA-PKcs was undetectable in M059J cell line, while Ku and PARP were detected at similar levels in both M059J and control M059K cell lines in immunoblot assay ( Figure 4a ). We prepared crude nuclear extracts from M059K and M059J cells and incubated these with [g-32 P]ATP in the presence or absence of dsDNA. We detected dsDNA-dependent phosphorylation of several proteins that were undetectable in M059J cells (Figure 4b ), including a prominent large band (arrowhead; probably 465 kDa DNA-PKcs) and a band of about 120 kDa (asterisk; probably PARP). The same reaction mixtures were immunoprecipitated with anti-PARP antibody ( Figure  4c ). Phosphorylated PARP protein was detected in the presence of dsDNA in the M059K cell nuclear extract but not in the M059J cell nuclear extract, indicating that it is DNA-PK that phosphorylated PARP in this assay.
Suppression of the automodi®cation activity of PARP by DNA-PK in vitro
To study the eects of DNA-PK on the PARP activity, puri®ed human DNA-PK was incubated with puri®ed human PARP expressed in E. coli together with [ 32 P]NAD in the presence or absence of dsDNA. In the presence of dsDNA, PARP gave two groups of heavily labeled smeared bands, one at the top and the other at the bottom, representing auto-poly(ADPribosyl)ated PARP and poly(ADP-ribose), respectively ( Figure 5a, lane 3) . When DNA-PK was added, the labeled bands corresponding to DNA-PKcs, Ku 70, and Ku 80 were observed (Figure 5a Preferential binding of Ku complex to a short dsDNA in EMSA Although both Ku complex and PARP are known to bind to the ends of dsDNA, little is known about the relative eciencies of these two events. To address this issue, we employed EMSA with the HIRE-probe. The DNA-bound fraction from MT-2 cells (see Figure 1a ) gave two shifted bands beside the material stuck near the origin in this assay (Figure 6a , lane 1). The antibody against Ku 80 supershifted these two bands ( Figure 6a, lane 2) . On the other hand, an antibody against PARP had no eects on the formation of the lower two major EMSA bands (Figure 6a, lane 3) . The same antibody supershifted the smeared bands that was detected by EMSA when the puri®ed PARP protein was used (Figure 6b ). Thus, under these conditions, the two major complexes formed with the unfractionated PARP/DNA-PK material do not seem to contain PARP as their major component.
Association of Ku complex with PARP
To examine whether Ku complex binds to PARP directly, we performed immunoprecipitation with MT-2 cell nuclear extract under mild conditions. The protein-G-bound immune complex was treated with DNase I to release proteins that are bound via DNA, and after extensive washing of the resin, the bound proteins were analysed by immunoblotting with antibodies against Ku complex and PARP (Figure 7) . The result indicates that at least a fraction of Ku proteins and PARP, once complexed, stayed bound to each other even after DNase I treatment. 
Discussion
In this study, we have found that PARP can be phosphorylated by DNA-PK in the presence of dsDNA in vitro. Lees-Miller et al. (1992) previously reported that a minimal target sequence for phosphorylation by DNA-PK consists of a serine or threonine residue adjacent to a glutamine residue with no nearby basic amino acids. The human PARP has at least ®ve candidate DNA-PK phosphorylation sites: i.e. serine residues 179, 720, 726, 873 and 910. DNA-PK could phosphorylate the 88 kDa mutant PARP (PARPDN) devoid of the N-terminal DNA binding domain (residues 7 ± 232), suggesting that the remaining central and/or C-terminal portion of PARP contains a major target(s) for the phosphorylation by DNA-PK. Although it has been well-documented that ecient phosphorylation by DNA-PK occurs only when target proteins are bound to DNA, DNA-PK may also phosphorylate some proteins having no DNA-binding activity, such as human heat shock protein hsp90 and a-casein, in a dsDNA-dependent manner Anderson, 1989 and Carter et al., 1990) . The PARPDN mutant also provides additional evidence that DNA binding of target proteins is not prerequisite for DNA-PK-mediated phosphorylation.
Co-existence of DNA-PK markedly inhibited the PARP activity in vitro as assessed by its auto-ADPribosylating activity (Figure 5a ). This inhibition was observed both in the absence and presence of ATP, suggesting that the phosphorylation of PARP by DNA-PK is probably not responsible for this inhibition. The EMSA results ( Figure 6 ) indicated that dsDNA preferentially bound to Ku complex when the mixture of DNA-PK and PARP were used. Therefore, one possible mechanism of the inhibition of PARP by DNA-PK would be a competition for DNA ends between these enzymes, although more direct mechanism may also be involved.
In the initial anity-puri®cation experiment, the HIRE-binding fraction contained similar amounts of DNA-PK subunits and PARP (Figure 1a) . The EMSA result (Figure 6a ), however, indicated preferential binding of Ku complex to the HIRE probe. Although we do not know the exact reason for this apparent discrepancy, several possible explanations can be oered. First, one dierence between these two experiments was the size of the DNA substrate: the DNA used for the anity puri®cation was concatemers of the 46 bp HIRE oligonucleotide, while the EMSA probe was the monomer. Thus, PARP may have lower anity for shorter DNA fragment in the presence of Ku complex. Second, another dierence between these two experiments was the concentration of HIRE DNA used: about 0.1 ± 0.2 mg/ml in EMSA and about 20 mg/ ml in DNA anity puri®cation. In the latter case, the local DNA concentration should be even higher since they are localized on the surface of the beads. Thus, at higher DNA concentration, PARP may exhibit a higher anity to the DNA which is comparable to that of Ku complex. Third, as mentioned above, EMSA with PARP/DNA-PK mixture always gave rise to a relatively large complex stuck at the origin in PAGE. This complex may correspond to the major component of the HIRE-bound fraction in the anity puri®cation, which probably contains both DNA-PK and PARP, and the two lower bands detected in the EMSA (Figure 6a ), which contained only Ku proteins, may represent minor components in the anity puri®cation. In any event, the immunoprecipitation Figure 5 Functional interaction between DNA-PK and PARP. (a) Eects of DNA-PK on the PARP activity. The puri®ed human PARP protein expressed in E. coli (0.5 mg) (lanes 2 ± 5) and/or puri®ed DNA-PK (1.5 mg) (lanes 1, 4 and 5) were incubated with [ 32 P]NAD in the presence (lanes 1, 3 ± 5) or absence (lane 2) of poly(dI-dC).poly(dI-dC) (0.2 mg). The eects of cold ATP (0.2 mM) was also examined (lane 5). The reaction products were analysed by SDS ± PAGE, followed by autoradiography. (b) Eects of PARP on the DNA-PK activity. The puri®ed human PARP protein expressed in E. coli (0.3 mg) (lanes 3 ± 6) and/or puri®ed DNA-PK (0.5 mg) (lanes 1, 2, 4 ± 6) were incubated with [g-32 P]ATP in the presence (lanes 2, 3, 5 and 6) or absence (lanes 1 and 4) of poly(dI-dC).poly(dI-dC) (0.2 mg). The eects of cold NAD (0.2 mM) was also examined (lane 6). The reaction products were analysed by SDS ± PAGE, followed by autoradiography experiment coupled with DNase-treatment (Figure 7) suggested direct or at least close association between Ku 70/80 and PARP.
We have also shown in this study that DNA-PKcs and Ku 70/80 complex can be ADP-ribosylated by PARP in vitro ( Figure 5 ). In the presence of ATP, reduced ADP-ribosylation of DNA-PKcs, but not of Ku 70/80 complex, was observed. One possible explanation for this phenomenon is that autophosphorylated DNA-PK takes such a conformation that does not allow ADP-ribosylation by PARP. Alternatively, phosphorylation of PARP itself might have altered its substrate speci®city so that PARP no longer recognized DNA-PKcs as its substrate. In any event, our results suggest a phosphorylation-dependent regulation of ADP-ribosylation by PARP. Importantly, the presence of PARP had no eects on the autophosphorylation activity of DNA-PK. This, however, does not necessarily mean that PARP plays no role in the regulation of DNA-PK function. In fact, Ruscetti et al. (1998) have recently reported that the phosphorylation of human RPA (34 kDa subunit) and p53 by DNA-PK in vitro was stimulated by PARP in the presence of NAD. This stimulation was directly correlated with the ADP-ribosylation of DNA-PKcs. Thus, at least in some cases, PARP and DNA-PK mutually regulate the function of each other.
PARP is believed to be the ®rst protein that binds at a DNA-break to protect the newly generated DNA ends from exonuclease attacks and aberrant exchanges of DNA sequences (Lindahl et al., 1995) . On the other hand, if DNA-PK is to play a role in strand break repair, this enzyme needs to reach the site and then probably replace PARP. Our observations in this study may re¯ect such process. First, to allow such replacement to occur, PARP must give in DNA ends when DNA-PK comes; when both PARP and DNA-PK were present, Ku complex (i.e. DNA-binding component of DNA-PK) showed higher anity to the DNA than did PARP in EMSA (Figure 6 ). Secondly, once DNA-PK has reached the site DNAbreak, PARP would no longer need to remain active and may be switched o; DNA-PK inhibited the auto-ADP-ribosylation by PARP in vitro ( Figure 5) . Morrison et al. (1997) generated mice lacking both DNA-PK (i.e. SCID) and PARP. These mice express both CD4 and CD8 co-receptors in thymocytes (i.e. suppression of a SCID phenotype) and develop T-cell lymphoma at high frequency, suggesting some functional interaction between DNA-PK and PARP in V(D)J recombination as well as in tumorigenesis. In light of our ®ndings as well as those by Ruscetti et al., such phenomena may be explained if one assumes that recombination, including those involved in V(D)J joining, is negatively regulated by PARP and that DNA repair is positively regulated by DNA-PK. Based on our ®nding that DNA-PK inhibits PARP, the SCID (i.e. DNA-PK-de®cient) phenotype may be explained as a consequence of a deregulated PARP activity, namely an increased suppression of recombination. Also, based on the ®ndings by Ruscetti et al. that PARP stimulates the activity of DNA-PK at least on certain substrates, the phenotype of PARP-de®cient mice, for instance, the increased sensitivity to DNAdamaging agents and no apparent problems with V(D)J recombination , may be explained as a consequence of the lack of stimulation for DNA-PK activity, namely less active DNA repair. This model predicts that the problems with V(D)J Figure 7 Interaction of Ku complex with PARP. Nuclear extract from MT-2 cells was immunoprecipitated with anti-Ku or PARP antibody. Normal rabbit IgG was used as a negative control. The precipitates absorbed on protein-G-Sepharose resin were incubated with DNase I (10 U). After extensive washing of the resin, the bound proteins were analysed by immunoblotting with antibodies against Ku complex and PARP recombination found in SCID mice will be relieved when PARP is additionally deleted, since the negative eector for DNA-PK is now missing. Likewise, it predicts that an equally de®cient, if not worse, phenotype will be expressed in terms of DNA repair in the double mutant mice, since they lack both the positive regulator for repair (DNA-PK) and its stimulator (PARP). It will be of interest to test these predictions.
Although it is well-documented that DNA damage induces p53, how this is achieved is still unclear. Shieh et al. (1997) reported that DNA damage induces phosphorylation of p53 at serine 15 by DNA-PK. This phosphorylation stabilizes p53 by preventing mdm2-association. DNA-PK and ATM, another member of nuclear PI-3-kinase family, are involved in the activation of c-Abl protein kinase in response to DNA damage, and this may in part mediate DNAdamage-induced G1-arrest Baskaran et al., 1997; Shafman et al., 1997) . DNA damage also triggers a direct interaction between p53 and c-Abl (Yuan et al., 1996) . On the other hand, Vaziri et al. (1997) reported that PARP associates with and post-translationally activates p53. Inhibition of PARP activity by a chemical inhibitor abrogates the induction of p21 and mdm2 in response to DNA damage (Vaziri et al., 1997) . Similarly, primary ®broblasts from PARP 7/7 mice shows reduced basal expression of p53 as well as inability to express high levels of p53 in response to DNA damage (Agarwal et al., 1997) , suggesting that PARP is a key component of p53 damage response. All these ®ndings point to the importance of functional interplay between DNA-PK and PARP in DNA-damage response. Our ®ndings add an interesting new pathway to this scheme: direct mutual modi®cation and regulation between PARP and DNA-PK.
Materials and methods

Cell culture
MT-2, HTLV-I-infected human T-cells, were maintained in RPMI1640 medium supplemented with 10% heat-inactivated fetal calf serum (FCS) at 378C in a humidi®ed 5% CO 2 atmosphere. M059K and M059J cell lines were a kind gift by Dr Turner (Lees-Miller et al., 1995) . These were similarly maintained in Dulbecco's modi®ed Eagle's medium supplemented with 10% heat-inactivated FCS at 378C.
Puri®cation of DNA-PK and PARP
Two complementary oligonucleotides named HIRE (HTLV-1 internal regulatory element) (Ariumi et al., 1997) , 5'-AGCT-TGAATTCAGTTCTGCCCAGTTCTGCCCAGTTCTGCC-CA-3' and 5'-AGCTTGGGCAGAACTGGGCAGAACTG-GGCAGAACTGAATTCA-3', were synthesized. They were 5'-phosphorylated, annealed, and ligated to yield oligomers. The DNA oligomers were covalently attached to the anity latex particles as described by Kawaguchi et al. (1989) . MT-2 cell nuclear extracts were prepared according to Dignam et al. (1983) . Nuclear extracts were incubated with ssDNA (15 mg) and poly(dI-dC).poly(dI-dC) (5 mg, Pharmacia), added to the anity latex particles, and allowed to stand for 30 min with occasional mixing in the binding buer containing 10 mM HEPES (pH 7.9), 50 mM NaCl, 5% glycerol, 1 mM EGTA and 1 mM dithiothreitol (DTT). The binding reaction was terminated by brief centrifugation to separate the particles from the supernatant. The particles were washed ®ve times with the buer containing 10 mM HEPES (pH 7.9, 200 mM NaCl, 5% glycerol, 1 mM EGTA, 0.01% NP-40 and 1 mM DTT. After elution of proteins in the buer containing 1 M NaCl, the proteins were fractionated on a 7.5% SDS polyacrylamide gel and visualized by staining with Coomassie brilliant blue or silver (silver stain kit, Wako). For amino acid sequencing, the protein band in the gel was blotted onto the Immobilon membrane (Millipore), and the blotted band was excised and washed with pure water. Amino acid sequences of the fragments obtained by digestion with Lys-C were analysed as described by Kamata et al. (1998) .
UV cross-linking
End-labeled probe using bromo-dUTP was incubated with MT-2 nuclear extracts in the binding buer containing 10 mM HEPES (pH 7.9), 50 mM NaCl, 5% glycerol, 1 mM EGTA and 1 mM DTT. The reaction mixture was UV irradiated for 20 min using the inverted transilluminator, and then treated with DNase I at 378C for 30 min. Then, the mixture was subjected to elecrophoresis on a 7.5% SDSpolyacrylamide gel. After silver staining, the gel was autoradiographed. Two unlabeled competitors, HIRE or DHIRE (three tandem repeats of AGTTCT), were also incubated with the reaction mixture for competition experiments.
Southwestern blotting experiment
DNA anity puri®ed proteins were electrophoresed in 7.5% SDS ± polyacrylamide gel and transferred onto the Immobilon ®lter. The ®lter was pre-incubated in the binding buer containing 10 mM HEPES (pH 7.9), 50 mM NaCl, 5% glycerol, 1 mM EGTA, 1 mM DTT, 50 mg/ml poly(dIdC).poly(dI-dC) and 5% skim milk, and then incubated in the binding buer containing the end-labeled HIRE probe. The ®lter was washed with the binding buer containing 0.2 M KCl three times and autoradiographed.
DNA-PK assay
Puri®ed human DNA-PK from HeLa cells (0.5 mg, Promega) was incubated with the renatured human PARP protein or the PARPDN protein expressed in E. coli (3 mg) (Ikejima et al., 1990) and [g-32 P]ATP with or without poly(dIdC).poly(dI-dC) (0.2 mg, Pharmacia) in a reaction mixture (30 ml) containing 10 mM HEPES (pH 7.9), 50 mM NaCl, 10 mM MgCl 2 , 5% glycerol, 1 mM EGTA and 1 mM DTT. After incubation at 308C for 10 min, the reaction mixture was subjected to SDS ± PAGE and phosphorylation was detected by autoradiography. The renatured human PARP protein was prepared as follows: immunoprecipitates with anti-PARP antibody were prepared from nuclear extracts of MT-2 cells and subjected to SDS ± PAGE. The 115 kDa PARP band was eluted and precipitated with ®ve volumes of ice-cold acetone. The precipitates were dissolved in the buer containing 50 mM Tris-HCl (pH 8.0), 0.1 mM EDTA, 1 mM DTT, 0.1 mg/ml BSA, 150 mM NaCl, 0.1% NP-40, and 6 M guanidine hydrochloride, followed by renaturation in the buer containing 10 mM HEPES (pH 7.9), 50 mM NaCl, 10 mM MgCl 2 , 5% glycerol, 1 mM EGTA and 1 mM DTT.
PARP assay
Puri®ed human PARP protein expressed in E. coli (0.5 mg) (Ikejima et al., 1989) was incubated with human DNA-PK puri®ed from HeLa cells (1.5 mg, Promega) and [ 32 P]NAD with or without poly(dI-dC).poly(dI-dC) (0.2 mg, Pharmacia) in a reaction mixture (30 ml) containing 10 mM HEPES (pH 7.9), 50 mM NaCl, 10 mM MgCl 2 , 5% glycerol, 1 mM EGTA and 1 mM DTT. After incubation at 308C for 10 min, the reaction mixture was subjected to SDS ± PAGE, and ADP-ribosylation was detected by autoradiography.
Electrophoretic mobility shift assays (EMSAs)
The end-labeled HIRE (HTLV-I internal regulatory element) probe (46 bp, three tandem repeats of AGTTCTGCCC) (Ariumi et al., 1997) was incubated with the DNA-anitypuri®ed protein or the renatured protein in the binding buer containing 10 mM HEPES (pH 7.9), 50 mM NaCl, 5% glycerol, 1 mM EGTA, and 1 mM DTT. After incubation at room temperature for 30 min, the reaction mixture was subjected to electrophoresis for 2 h at 150 V on 4% nondenaturing polyacrylamide gel in 16TAE buer containing 40 mM Tris-acetate and 1 mM EDTA. For supershift assays, 2 ml of the appropriate antibody was added to the binding reaction 15 min prior to the loading on the gel.
Immunoprecipitation
Nuclear extracts from MT2 cells were pre-cleared with 30 ml of protein-G-Sepharose (Pharmacia), and the supernatant was incubated with 10 ml each of anti-PARP polyclonal antibody, human anti-Ku serum (Mimori et al., 1986) , or normal rabbit IgG (5 mg) and normal human IgG (5 mg) mixture for 60 min at 48C. The precipitates were absorbed on the protein-G-Sepharose resin, and the resin was washed four times with 600 ml of binding buer containing 10 mM HEPES (pH 7.9), 50 mM NaCl, 10 mM MgCl 2 , 5% glycerol, 1 mM EGTA and 1 mM DTT. The resin was then incubated with 10 U of DNase I (Pharmacia FPLCpure) in a reaction mixture (100 ml) containing the binding buer without EGTA for 10 min at 308C and washed four times with 600 ml of binding buer. After elution by boiling the resin for 5 min in 16Laemmli sample buer containing 50 mM Tris-HCl (pH 6.8), 2% SDS, 0.1% bromophenol blue (BPB), 10% glycerol and 5% 2-mercaptoethanol, the proteins were fractionated with a 7% SDS polyacrylamide gel, followed by immunoblotting with the anti-PARP or anti-Ku serum.
